{
    "clinical_study": {
        "@rank": "73747", 
        "acronym": "HHD", 
        "arm_group": [
            {
                "arm_group_label": "EDSS Score 0-3.5", 
                "description": "21 Subjects Total : 7 with normal to mildly limited walking"
            }, 
            {
                "arm_group_label": "EDSS Score  4.0-5.5", 
                "description": "21 Subjects total: 7 subjects with moderately limited walking ability."
            }, 
            {
                "arm_group_label": "EDSS Score  6.0-7.5", 
                "description": "21 Subjects total: 7 subjects with severely limited walking ability"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate a method of testing the strength of five key lower limb muscle groups using a\n      hand-held strength gauge (dynamometer)."
        }, 
        "brief_title": "Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Purpose of this study is to assess the intra-rater and inter-rater reliability of a\n      hand-held dynamometer (HHD) in the assessment of lower limb strength in patients with\n      Multiple Sclerosis.\n\n      Also to establish a standardized strength testing procedure for key lower limb muscle groups\n      using a HHD fo research and clinical purposes in Multiple Sclerosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stable patients with clinically definite Multiple Sclerosis\n\n          -  No Multiple Sclerosis exacerbation 30 days prior to screening\n\n          -  No change in disease modifying therapy for 30 day prior to screening\n\n        Exclusion Criteria:\n\n          -  Inflammatory myopathy\n\n          -  Endocarditis, pericarditis o rother unstable heart disease\n\n          -  Cardiac surgery or myocardial infarction in the last 3  months\n\n          -  Decompensated congestive heart failure\n\n          -  Severe aortic stenosis\n\n          -  Severe pulmonary hypertension\n\n          -  Pulmonary embolus or infarction in the last 6 months\n\n          -  Uncontrolled hypertension by history or by screening or baseline diastolic blood\n             pressure >170 or systolic blood pressure >105\n\n          -  Concomitant neurodegenerative neurological disease such as Amyotrophic      Lateral\n             Sclerosis (ALS) Parkinsons or hemiplegic stroke\n\n          -  females who are pregnant\n\n          -  Cognitive deficits that would interfere with the subjects's ability to give informed\n             consent or preform study testing\n\n          -  Painful orthopedic condition affecting the lower limbs\n\n          -  Any other serious and/or unstable medical condition"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Stable patients with clinically definite Multiple Sclerosis, aged 18 over, no Multiple\n        Sclerosis exacerbation or change in disease modifying therapy for 30 days prior to\n        screening. Subjects will fall into 1 of 3 EDSS catagories: 0-3.5; 4.0-5.5; 6.0-7.5."
            }
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01749943", 
            "org_study_id": "US-AVX-11-10213"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kirkland", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98034"
                }, 
                "name": "MS Center at Evergreen Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Validation of a Hand-Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics", 
        "overall_official": {
            "affiliation": "MS Center at Evergreen Hospital", 
            "last_name": "Theodore R Brown, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To assess the intra-rater and inter-rater reliability of a hand-held dynamometer(HHD) in the assessment of lower limb strength in patients with Multiple Sclerosis.\nTo establish a standardized strength testing procedure for key lower limb muscle groups using a HHD for research and clinical purposes in Multiple Sclerosis.", 
            "measure": "Assessment of HHD", 
            "safety_issue": "No", 
            "time_frame": "Outcome measures will be assessed once we have captured all data points for all 21 subjects."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01749943"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "to establish a standardized strength testing procedure for key lower limb muscle groups using a Hand-held dynamometer for research and clinical purposes in Multiple Sclerosis.", 
            "measure": "Validation of a Hand-held dynamometer for assessment of lower limb muscle strength.", 
            "safety_issue": "No", 
            "time_frame": "outcome measures will be assessed once we have captured all data points for all 21 subjects"
        }, 
        "source": "Brown, Theodore R., M.D., MPH", 
        "sponsors": {
            "collaborator": {
                "agency": "Biogen Idec", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Brown, Theodore R., M.D., MPH", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}